IGG SUBCLASS DEFICIENCY ASSOCIATED WITH CORTICOSTEROIDS IN OBSTRUCTIVE LUNG-DISEASE

被引:26
作者
KLAUSTERMEYER, WB
GIANOS, ME
KUROHARA, ML
DAO, HT
HEINER, DC
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024
[2] UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DIV PEDIAT IMMUNOL,TORRANCE,CA 90509
[3] VET ADM MED CTR BRENTWOOD,DIV ALLERGY & IMMUNOL,MED SERV,LOS ANGELES,CA 90073
[4] VET ADM MED CTR BRENTWOOD,DIV ALLERGY & IMMUNOL,RES SERV,LOS ANGELES,CA 90073
关键词
D O I
10.1378/chest.102.4.1137
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
IgG subclass levels were measured in three groups of adult patients with obstructive airways disease to discern the relationships among depressed IgG subclass levels, chronic corticosteroid use, and recurrent sinopulmonary infections. Group 1 consisted of patients with corticosteroid-dependent bronchial asthma, group 2 patients had corticosteroid-dependent chronic bronchitis/emphysema, and group 3 was comprised of asthma patients not requiring oral corticosteroids but associated with recurrent sinopulmonary infections. One or more IgG subclass deficiencies were noted in 66.7 percent of group 1, 46.7 percent of group 2, and 6.7 percent of group 3. Significant differences were noted between groups 1 and 3 (p=.0008) and between groups 2 and 3 (p=.018), but not between groups 1 and 2 (p=.5). IgG1 deficiency was the most common subclass deficiency found, 14 (77.8 percent) of 18 patients with detectable subclass deficiency demonstrated IgG1 deficiency. In this study poplation, IgG subclass level deficiencies appeared to be secondary to long-term low-dose corticosteroid therapy.
引用
收藏
页码:1137 / 1142
页数:6
相关论文
共 26 条
[1]  
BECK CS, 1981, AM REV RESPIR DIS, V124, P94
[2]  
BERGER W, 1978, ANN ALLERGY, V41, P67
[3]   IMPAIRED LUNG-FUNCTION IN PATIENTS WITH IGA DEFICIENCY AND LOW-LEVELS OF IGG2 OR IGG3 [J].
BJORKANDER, J ;
BAKE, B ;
OXELIUS, VA ;
HANSON, LA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :720-724
[4]  
BUCKLEY CE, 1970, J IMMUNOL, V105, P964
[5]  
FAHEY JL, 1965, J IMMUNOL, V94, P84
[6]   GLUCOCORTICOSTEROID THERAPY - MECHANISMS OF ACTION AND CLINICAL CONSIDERATIONS [J].
FAUCI, AS ;
DALE, DC ;
BALOW, JE .
ANNALS OF INTERNAL MEDICINE, 1976, 84 (03) :304-315
[7]  
GERRARD JW, 1980, ANN ALLERGY, V44, P261
[8]  
GORDON EH, 1984, ANN ALLERGY, V53, P476
[10]   ADRENOCORTICAL HORMONES IN INFECTION AND IMMUNITY [J].
KASS, EH ;
FINLAND, M .
ANNUAL REVIEW OF MICROBIOLOGY, 1953, 7 :361-388